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Sunday, February 3, 2013 63aconclude that the existence of intermediate states on the folding and unfolding
pathways are not mandatory and, in the simple case of a polypeptide with
a non-charged and non-polar inserting end, the folding and unfolding appears
as an all-or-none transition. This work was supported by NIH grants
CA133890 and GM073857 to OAA, DME, YRK and NIH grants CA138468
to YRK.
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Michael A. Weiss, Jonathan Whittaker.
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Recent advances in the crystallographic analysis of the insulin receptor and its
mode of activation by insulin provide a novel foundation for the design of in-
sulin analogues for the treatment of diabetes mellitus. The structure of the re-
ceptor ectodomain, elucidated by M. Lawrence, C. Ward, and their colleagues
in Melbourne, Australia, revealed an inverted-V dimer in which the primary
insulin-binding site comprises the N-terminal beta-helix of one alpha-subunit
and a nascent C-terminal alpha-helix from the other. Contact sites and evidence
for bidirectional induced fit have been obtained from cross-linking studies em-
ploying synthetic photo-reactive insulin derivatives or biosynthetic photo-
reactive receptor variants engineered by expanded genetic-code technology.
Such basic advances have enabled translational progress toward the develop-
ment of ultra-concentrated and rapid-acting insulin analogs designed to address
unmet clinical needs of minority populations, including African-American
women and indigenous Americans with diabetes complicated by obesity and
marked insulin resistance. Together, our biochemical, biophysical, and struc-
tural studies illustrate the potential value of basic science to multi-
disciplinary approaches to health-care disparities among disadvantaged
populations.
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The P2X receptor, a trimeric, non-selective cation channel activated by extra-
cellular ATP, is believed to play important roles in nociception and inflamma-
tion. Therefore, understanding the underlying structure–function relationships
of the P2X receptor protein will help elucidate the molecular mechanics of nox-
ious stimuli processing and aid in the design of pain-relieving therapeutic
agents. Previous studies have utilized Cd2þ metal bridging in the transmem-
brane domain and patch-clamp electrophysiology to probe the Apo- and
ATP-bound forms of introduced-cysteine mutant P2X constructs heterolo-
gously expressed in HEK293 cells. These studies have identified a number of
constructs in which Cd2þ application results in inhibition of ATP-activated
currents (Li, 2010; Khakh, 2010). Building on this work, we have identified
a novel Cd2þ bridging site, away from the central ion permeation pathway,
that potentiates macroscopic rP2X2 currents. We have characterized the amino
acid residues and subunits participating in bridge formation, and are currently
investigating the mechanistic basis of current modification through single-
channel recordings.
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Despite repeated efforts, an atomic-resolution structure of the anthrax toxin
protective antigen (PA) in its membrane-embedded pore form remains elu-
sive. Recently, we determined the structure of the PA-pore at 16.0 A˚ resolu-
tion using cryo-electron microscopy (cryo-EM) which signified progress but
remained short of the desired atomic resolution. In this work, we employed
a computational prediction approach and constructed the model structure of
the heptameric PA-pore using I-TASSER complemented by the TACOS force
field. Importantly, the electron density map obtained from the cryo-EM was
used as an additional restraint during the modeling process. The overall struc-
ture was mushroom-shaped with a broad ‘‘cap’’ region and a narrow elon-
gated ‘‘stem’’ in the form of a b-barrel. Remarkably, the b-barrel was not
a straight cylinder, but ‘‘cigar-shaped’’ with a prominent bulge followed by
a constriction region. The Poisson-Boltzmann electrostatic potential revealedthat the structure featured rings of positively charged patches followed by
negatively charged patches which can be potentially used to explain the pro-
posed Brownian-ratchet mechanism of protein translocation at the PA-pore. A
number of low-resolution structural features obtained previously from muta-
genesis studies were used to initially corroborate the validity of the structure.
Finally, grand-canonical Monte Carlo/Brownian dynamics simulations were
conducted to calculate the ion conductance (KCl) and selectivity across the
pore, which were found to be remarkably close to the experimental measure-
ments and far better than those from previous modeling attempts of the PA-
pore structure.
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Pulmonary surfactant is a lipoprotein complex which reduces surface tension
to prevent alveolar collapse. At the same time, surfactant also contributes to
the protection of the large respiratory surface from the entry of pathogens. It
is composed of around 92% lipids and 8% of specific surfactant proteins by
mass. One of these proteins is SP-A, a hydrophilic glycoprotein of the collectin
family. The main function of this protein is related with host defense. How-
ever, previous studies showed that SP-A also aids in the formation and surface
behavior of surfactant films at the air-water interface. Humans possess two SP-
A genes expressing protein variants SP-A1 and SP-A2. Although their specific
or combined activity is not well understood, it has been shown that both gene
products are necessary for tubular myelin formation, an extracellular structural
form of surfactant. The goal of the present study was to investigate potential
differences in the biophysical behavior of surfactants containing human SP-
A1, SP-A2, or both. For this purpose we have studied pulmonary surfactant
from humanized transgenic mice expressing hSP-A1, hSP-A2, or both human
SP-As instead of the endogenous murine protein, in the Captive Bubble Surfac-
tometer (CBS), which simulates alveolar interfacial compression-expansion
dynamics. We observed that surfactant containing both hSP-A1 and hSP-A2
reaches lower surface tension after initial and post-expansion interfacial ad-
sorption than surfactants containing only hSP-A1 or hSP-A2. Under interfacial
cycling conditions (Quasi-static or Dynamic compression-expansion regimes)
surfactant films containing both hSP-A1 and hSP-A2 also showed better per-
formance than surfactant containing only SP-A1 or SP-A2. We conclude
that the simultaneous presence of hSP-A1 and hSP-A2 proteins permits surfac-
tant to adopt a particularly favorable structure with optimal functional
properties.
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Pulmonary surfactant is a specialized lipid-protein complex, which essential
function is to stabilize the gas exchange surface of the respiratory epithelium
against physical forces tending to its collapse. Hydrophobic surfactant proteins
SP-B and SP-C are critical to promote very rapid adsorption of phospholipids
into the interface and to stabilize the surface active film along the compression-
expansion respiratory cycles. The composition of pulmonary surfactant varies
slightly between species but in general it consists of 90% lipids by weight and
8-10% proteins, including the specific surfactant proteins SP-A, SP-B, SP-C
and SP-D. The main feature of protein SP-C (35 amino acids, 3.7kDa) is its ex-
treme hidrophobicity. Structurally it consists of a transmembrane a-helical
stretch and a short N-terminal segment. The positions 5 and 6 of SP-C sequence
are in most species occupied by two cysteines that are palmitoylated. It has
been proposed that SP-C interacts with cholesterol-rich phases of surfactant
membranes and films, contributing to modulate the interfacial behavior of sur-
factant in the alveoli but evidence remains uncertain.
Our aim in this work was to elucidate how palmitoylation influences the inter-
action of SP-C with lipids in different surfactant-mimetic systems, in the pres-
ence or absence of cholesterol. To this end, we have compared the secondary
structure, tilting and lipid-protein interactions of native palmitoylated SP-C pu-
rified from porcine lungs with the behavior of non-palmitoylated recombinant
